The FDA panel rejects Otsuka's PTSD drug combination. Humana's lawsuit challenging Medicare rating downgrades is dismissed. Spain reports an avian flu outbreak, causing global supply concerns.

Humana losing star ratings is a big set-back that lead to its share price falling by 7.5% before paring losses.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments ...

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. government's reduction in its ...

Humana (HUM) reportedly lost its legal challenge to overturn a decision that slashed its Medicare Advantage bonus payments, ...